JP2024522183A5 - - Google Patents
Info
- Publication number
- JP2024522183A5 JP2024522183A5 JP2023575827A JP2023575827A JP2024522183A5 JP 2024522183 A5 JP2024522183 A5 JP 2024522183A5 JP 2023575827 A JP2023575827 A JP 2023575827A JP 2023575827 A JP2023575827 A JP 2023575827A JP 2024522183 A5 JP2024522183 A5 JP 2024522183A5
- Authority
- JP
- Japan
- Prior art keywords
- oxadiazole
- methoxyphenyl
- pyridazin
- amine
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208918P | 2021-06-09 | 2021-06-09 | |
| US63/208,918 | 2021-06-09 | ||
| PCT/US2022/032798 WO2022261296A1 (en) | 2021-06-09 | 2022-06-09 | Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522183A JP2024522183A (ja) | 2024-06-11 |
| JP2024522183A5 true JP2024522183A5 (https=) | 2025-06-18 |
Family
ID=82492690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575827A Pending JP2024522183A (ja) | 2021-06-09 | 2022-06-09 | 非標準ｇ四重鎖構造に結合する化合物ならびにそれを作製および使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240287054A1 (https=) |
| EP (1) | EP4352054A1 (https=) |
| JP (1) | JP2024522183A (https=) |
| AU (1) | AU2022288631A1 (https=) |
| CA (1) | CA3222837A1 (https=) |
| WO (1) | WO2022261296A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025184571A1 (en) * | 2024-03-01 | 2025-09-04 | City Of Hope | Pcna inhibitors for the treatment of myc family associated cancers |
| GB202414345D0 (en) * | 2024-09-30 | 2024-11-13 | Mycural Therapeutics Ab | New compounds and medical uses thereof |
| GB202414337D0 (en) * | 2024-09-30 | 2024-11-13 | Mycural Therapeutics Ab | New compounds and medical uses thereof |
| GB202414343D0 (en) * | 2024-09-30 | 2024-11-13 | Mycural Therapeutics Ab | New compounds and medical uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| CA1256638A (en) | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
| JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
| EP2304366A2 (en) * | 2008-05-30 | 2011-04-06 | Foster Wheeler Energia Oy | Method of and system for generating power by oxyfuel combustion |
| US10463649B2 (en) * | 2015-06-08 | 2019-11-05 | Texas Tech University System | Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors |
-
2022
- 2022-06-09 US US18/568,738 patent/US20240287054A1/en active Pending
- 2022-06-09 WO PCT/US2022/032798 patent/WO2022261296A1/en not_active Ceased
- 2022-06-09 AU AU2022288631A patent/AU2022288631A1/en active Pending
- 2022-06-09 JP JP2023575827A patent/JP2024522183A/ja active Pending
- 2022-06-09 EP EP22741091.7A patent/EP4352054A1/en active Pending
- 2022-06-09 CA CA3222837A patent/CA3222837A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522183A5 (https=) | ||
| EP3658538B1 (en) | Compounds and compositions for treating conditions associated with nlrp activity | |
| JP7050751B2 (ja) | Ｎｌｒｐ活性に関連する状態を処置するための化合物および組成物 | |
| US10377759B2 (en) | Brk inhibitory compound | |
| EP1846035B1 (en) | Combination therapy | |
| JP2024009851A (ja) | Ｐｄ－１／ｐｄ－ｌ１阻害剤 | |
| CA3094452A1 (en) | Combination product of bcl-2 inhibitor or bcl-2/bcl-xl dual inhibitor and btk inhibitor and use thereof in the prevention and/or treatment of diseases | |
| CN107344940B (zh) | Btk抑制剂及其用途 | |
| JP2016522246A5 (https=) | ||
| CA3056893A1 (en) | Compounds and compositions for treating hematological disorders | |
| US11401278B2 (en) | Macrocyclic indole derivatives | |
| CN118843630A (zh) | 作为pkmyt1抑制剂的杂芳族化合物及其用途 | |
| CN105899493A (zh) | 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物 | |
| TW200403210A (en) | Benzamide derivatives | |
| JP2015533181A (ja) | Ｐｉ３ｋ阻害剤としてのピロロトリアジノン誘導体 | |
| TW202019409A (zh) | Bcl-2抑制劑與利妥昔單抗和/或苯達莫司汀或bcl-2抑制劑與chop聯合用藥的協同抗腫瘤作用 | |
| US20250034202A1 (en) | Celastrol proteolysis targeting chimeras | |
| EP3019171A1 (en) | Substituted amidopyrazole inhibitors of interleukin receptor-associated kinases (irak-4) | |
| WO2022199676A1 (zh) | 稠合四环类化合物、其制备方法及其在医药上的应用 | |
| TW202024038A (zh) | 靶向突變哺乳動物蛋白質之小分子 | |
| CA2584303A1 (en) | Novel heterocycles | |
| US20240376073A1 (en) | Quaternary ammonium cation substituted compounds for the treatment of bacterial infections | |
| US20240277722A1 (en) | Cancer therapy using a combination of cdk7 inhibitor with an anti-cancer agent | |
| JP2022519764A (ja) | 二環式スルホンアミド | |
| JP2024511057A5 (https=) |